Suppr超能文献

亚临床甲状腺功能减退症中低密度脂蛋白/高密度脂蛋白的变化:冠心病的潜在危险因素

LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease.

作者信息

Althaus B U, Staub J J, Ryff-De Lèche A, Oberhänsli A, Stähelin H B

机构信息

Department of Medicine, University Hospital, Basel, Switzerland.

出版信息

Clin Endocrinol (Oxf). 1988 Feb;28(2):157-63. doi: 10.1111/j.1365-2265.1988.tb03651.x.

Abstract

The aim of the present study was to evaluate the lipid profiles (total cholesterol, triglycerides, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and the electrophoretic low-density lipoproteins and high-density lipoproteins) in patients with subclinical (n = 52) and overt hypothyroidism (n = 18) in comparison to normal controls (28 and 18, respectively), matched for age, sex and body mass index. Subclinical hypothyroidism was defined as a syndrome with normal free thyroxine and total thyroxine but elevated basal thyrotrophin levels and/or an exaggerated TSH response to oral thyrotrophin releasing hormone. In subclinical hypothyroidism there was an elevated LDL concentration (P less than 0.01), a diminished HDL fraction (P less than 0.05) and a borderline elevated LDL-C (not reaching the limit of significance, P = 0.07). Total cholesterol and triglyceride concentrations remained unaltered. For the whole group of patients and controls significant negative correlations were found between LDL-C and T4 (P less than 0.04), total cholesterol and free thyroxine-index (P less than 0.01); positive correlations could be demonstrated between LDL-C and basal TSH (P less than 0.03), the ratio total cholesterol/HDL-C and basal TSH (P less than 0.03), and triglycerides and basal TSH (P less than 0.01). Our data provide a possible explanation for the higher prevalence of coronary heart disease reported in subclinical hypothyroidism. There may well be a case for the detection and early treatment of such individuals.

摘要

本研究的目的是评估亚临床甲状腺功能减退患者(n = 52)和显性甲状腺功能减退患者(n = 18)的血脂谱(总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇以及电泳法检测的低密度脂蛋白和高密度脂蛋白),并与年龄、性别和体重指数相匹配的正常对照组(分别为28例和18例)进行比较。亚临床甲状腺功能减退被定义为一种综合征,其游离甲状腺素和总甲状腺素正常,但基础促甲状腺激素水平升高和/或对口服促甲状腺激素释放激素的促甲状腺激素反应过度。在亚临床甲状腺功能减退患者中,低密度脂蛋白浓度升高(P < 0.01),高密度脂蛋白部分降低(P < 0.05),低密度脂蛋白胆固醇临界升高(未达到显著水平,P = 0.07)。总胆固醇和甘油三酯浓度保持不变。对于所有患者和对照组,发现低密度脂蛋白胆固醇与T4之间存在显著负相关(P < 0.04),总胆固醇与游离甲状腺素指数之间存在显著负相关(P < 0.01);低密度脂蛋白胆固醇与基础促甲状腺激素之间存在正相关(P < 0.03),总胆固醇/高密度脂蛋白胆固醇比值与基础促甲状腺激素之间存在正相关(P < 0.03),甘油三酯与基础促甲状腺激素之间存在正相关(P < 0.01)。我们的数据为亚临床甲状腺功能减退患者中报告的冠心病患病率较高提供了一种可能的解释。对这类个体进行检测和早期治疗很可能是有必要的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验